NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/03/2024
Back to search
Official data from USPTO
ERWINAZE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
12/03/2024
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
07/29/2020
Registration date
12/03/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
12/03/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
3
Owner type
99
Owner location
Wiltshire, GB
Examiner
GADSON, SHARI
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "ERWINAZE" to the left of a multi-lined design.
Holders and representatives
Holders
Porton Biopharma Limited
Representatives
Rebecca Liebowitz VENABLE LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for treatment of blood cancer; pharmaceutical preparations and substances for the treatment of leukaemia; pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical compositions and preparations for treatment of leukaemia and cancerinjectable pharmaceutical compositions comprising compounds having asparaginase activity
Publications
History of USPTO decisions and trademark events.
46 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2024
PUBO
PUBLISHED FOR OPPOSITION
10/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/11/2024
OTHE
CASE RETURNED TO EXAMINATION
08/28/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/28/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
08/27/2024
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
07/10/2024
APET
ASSIGNED TO PETITION STAFF
07/08/2024
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
05/30/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/01/2024
EX5G
SOU EXTENSION 5 GRANTED
02/29/2024
EXT5
SOU EXTENSION 5 FILED
02/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/29/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/20/2023
EX4G
SOU EXTENSION 4 GRANTED
07/18/2023
EXT4
SOU EXTENSION 4 FILED
07/18/2023
EEXT
SOU TEAS EXTENSION RECEIVED
07/18/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/02/2023
EX3G
SOU EXTENSION 3 GRANTED
02/28/2023
EXT3
SOU EXTENSION 3 FILED
02/28/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/28/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/02/2022
EX2G
SOU EXTENSION 2 GRANTED
06/30/2022
EXT2
SOU EXTENSION 2 FILED
06/30/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/30/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/04/2022
EX1G
SOU EXTENSION 1 GRANTED
02/02/2022
EXT1
SOU EXTENSION 1 FILED
02/02/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/02/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/31/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/06/2021
PUBO
PUBLISHED FOR OPPOSITION
07/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/16/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/28/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/18/2020
GNRT
NON-FINAL ACTION E-MAILED
11/18/2020
CNRT
NON-FINAL ACTION WRITTEN
11/18/2020
DOCK
ASSIGNED TO EXAMINER
11/17/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/28/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/27/2020
NWAP
NEW APPLICATION ENTERED
08/01/2020
Continuous trademark protection
Get notified about every new filing that threatens ERWINAZE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.